Showing results (351-360 of 761) with videos related to

Sort By:
Pageof 77
Acta Neuropathologica Communications|March 24, 2021
Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer's pathophysiologyVijay K Ramanan, Timothy G Lesnick, Scott A Przybelski, et al.
Plos One|April 8, 2022
Poly (ADP-Ribose) and α-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severityFabrice Lucien, Eduardo E Benarroch, Aidan Mullan, et al.
Mitochondrion|August 23, 2024
Associations of mitochondrial genomic variation with successful neurological agingNicole Tamvaka, Michael G Heckman, Patrick W Johnson, et al.
JAMA Neurology|July 9, 2014
A 6.4 Mb duplication of the α-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlationsEleanna Kara, Aoife P Kiely, Christos Proukakis, et al.
Science Translational Medicine|October 15, 2020
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathiesChangyoun Kim, Alexandria Beilina, Nathan Smith, et al.
Plos Genetics|May 21, 2010
Abundant quantitative trait loci exist for DNA methylation and gene expression in human brainJ Raphael Gibbs, Marcel P van der Brug, Dena G Hernandez, et al.
Neurobiology of Aging|September 5, 2017
Establishing the role of rare coding variants in known Parkinson's disease risk lociIris E Jansen, J Raphael Gibbs, Mike A Nalls, et al.
Parkinsonism & Related Disorders|January 17, 2021
Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's diseaseMichael G Heckman, Catherine Labbé, Ana L Kolicheski, et al.
BMC Bioinformatics|April 18, 2018
Identification of missing variants by combining multiple analytic pipelinesYingxue Ren, Joseph S Reddy, Cyril Pottier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2007
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft, Ignacio F Mata, Owen A Ross, et al.
Pageof 77